Differences in T cell activation by lung immune cells
Author Information
Author(s): Kugathasan Kapilan, Roediger Elizabeth K, Small Cherrie-Lee, McCormick Sarah, Yang Pingchang, Xing Zhou
Primary Institution: McMaster University
Hypothesis
To what extent do alveolar and lung parenchymal CD11c+ antigen presenting cells differ in their ability to activate T cells?
Conclusion
Alveolar CD11c+ antigen presenting cells can activate antigen-primed T cells but are poor activators of naïve T cells compared to lung parenchymal and splenic counterparts.
Supporting Evidence
- Alveolar CD11c+ APCs are weak activators of naïve T cells compared to lung parenchymal and splenic CD11c+ APC populations.
- Alveolar space APCs can activate antigen-primed T cells to a similar extent as lung parenchymal and splenic APCs.
- Differential co-stimulatory molecule expression and cytokine responsiveness were observed among the three APC populations.
Takeaway
The immune cells in the lungs work differently; some are good at waking up tired T cells that have seen germs before, but not so good at waking up new T cells that have never seen germs.
Methodology
The study compared the phenotype and T cell activation capabilities of CD11c+ antigen presenting cells from the alveolar space, lung parenchyma, and spleen using various assays.
Limitations
The study primarily focused on murine models, which may not fully represent human immune responses.
Participant Demographics
Six- to 10-week-old female C57Bl/6 and Balb/c mice were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website